Leyla Hannbeck Chief Pharmacist Twitter: @LeylaHannbeck NMS - - PowerPoint PPT Presentation

leyla hannbeck chief pharmacist twitter leylahannbeck nms
SMART_READER_LITE
LIVE PREVIEW

Leyla Hannbeck Chief Pharmacist Twitter: @LeylaHannbeck NMS - - PowerPoint PPT Presentation

NMS effective engagement and delivery Leyla Hannbeck Chief Pharmacist Twitter: @LeylaHannbeck NMS statistics: 2014/15 and 2015/16 In the year 2014/15: 775,998 total number of NMS claimed 9,308 (80%) number of pharmacies


slide-1
SLIDE 1
slide-2
SLIDE 2

NMS – effective engagement and delivery

Leyla Hannbeck Chief Pharmacist

Twitter: @LeylaHannbeck

slide-3
SLIDE 3

NMS statistics: 2014/15 and 2015/16

  • In the year 2014/15:
  • 775,998 – total number of NMS claimed
  • 9,308 (80%) – number of pharmacies that provided service
  • 83 – average number of NMS per pharmacy
  • 2,366 – eligible pharmacies that did not delivery any NMS
  • Between April 2015 and January 2016 (10 months):
  • 603,141 – total number of NMS claimed
slide-4
SLIDE 4

NMS: introduction

  • NMS aims to provide early support to patients who

are newly prescribed a medicine for a long term condition

  • Four conditions/therapy covered by NMS include:
  • Antiplatelet/anticoagulant therapy
  • Asthma and COPD
  • Hypertension
  • Type 2 diabetes
  • Involves 3 stages:
  • Patient engagement
  • Intervention
  • Follow-up
slide-5
SLIDE 5

Barriers to delivering NMS

.

  • Time available: both patients time and pharmacist time
  • Capability and availability of support staff
  • Lack of staff engagement
  • Value and outcomes of the NMS service
  • Consultation room uninviting for the patient to enter
  • Consultation room being utilised for other services
  • Poor consultation styles and skills
  • Representatives collecting prescription for housebound patients
  • Failure to attend NMS appointments
  • Low prescription volume coinciding with low NMS uptake
slide-6
SLIDE 6

NMS: current service constraints

  • 3 staged process found to be cumbersome and even

unnecessary – some patients receive all support by end of intervention stage

  • In most cases, payment only received once all three

stages are complete - waste of pharmacists time if a patients do not attend at follow-up stage

  • NMS cannot be carried out to a carer, guardian or

parent– this takes away useful opportunities to help improve medicines adherence amongst certain patient groups

slide-7
SLIDE 7

NMS study

  • Independent evaluation of NMS conducted by

University of Nottingham and UCL Schools of Pharmacy

  • Commissioned by DH in 2012 with final report published in
  • 2014. ‘Understanding and Appraising the New Medicines

Service in the NHS in England’

  • Key finding: “NMS was effective at improving patients’

adherence to their new medicines by around 10%”

  • NMS increased number of patients taking their new

medicines from 67 to 78 out of every 100 patients

slide-8
SLIDE 8

NMS study: other important findings

  • No overall cost to the NHS of providing NMS –

the intervention costs were absorbed by reduced subsequent NHS contract costs

  • NMS was more successful than other more

expensive interventions

  • In terms of value, NMS reduced costs for the

NHS overall while also improving patient

  • utcomes
  • Each NMS saving the NHS on average £21.11
slide-9
SLIDE 9

NMS – effective delivery

slide-10
SLIDE 10
slide-11
SLIDE 11

NMS KPI

  • Check34 NMS KPI allows you to:
  • Manage and monitor NHS services
  • Understand branch, company performance
  • Benchmark your pharmacy performance against branches

within the same company, other local pharmacies and national averages

  • Identify root causes for failing to meet targets
  • Conduct regular training and quality checks to ensure staff

are aware of the service

  • View up to 24 months history and trend analysis
slide-12
SLIDE 12

NMS pack

New Medicine Service outline Medicines covered by the NMS Anticoagulant or antiplatelet therapy Asthma and chronic obstructive pulmonary disease (COPD) Hypertension Type 2 diabetes Healthy living advice Recruiting and retaining patients Patient consent Communicating with patients Interview schedule The pharmacy team Engaging with GPs Record keeping Payment Access to the Summary Care Record – issues pharmacists should bear in the mind when accessing Ready to provide the NMS – so you can decide whether or not to provide this service Checklist for pharmacies – a checklist to help you ensure that the NMS is running as effectively as possible.

slide-13
SLIDE 13
slide-14
SLIDE 14

EPBP: overview

Assess

SWOT and Gap analysis Drug Tariff guide KPIs Job descriptions Apprenticeships GPhC inspections CPAF

Plan

Achievement plan template Skills matrix Action plan template with prioritisation matrix

Develop

Alternative private services PGD services Automated dispensary systems and pharmacy robots Benefits of renting out a consultation room Leadership

Promote

Social media

Review

Improving your pharmacy business Daily/weekly checklists

slide-15
SLIDE 15

SWOT analysis example

S – Strengths Characteristics of the business that give it an advantage over competitors W – Weaknesses Characteristics of the business that put it at a disadvantage compared to others – potential areas for improvement

 What do you do better than your competition?  What additional service(s) does your pharmacy offer customers/patients compared to other local pharmacy businesses?  Does your pharmacy have any unique selling points?  What does your competition do better than you?  What do they offer that you don’t?  Do you have enough manpower to accommodate further growth of the business?

O – Opportunities Opportunities to enhance offering/increase sales T – Threats Factors that could cause/enhance issues in future

 What other services/products could you offer?  Are there any local pharmaceutical needs that are not currently being met? This information can be found in the local Pharmaceutical Needs Assessment (PNA) document produced by local authority health and wellbeing boards  What do your customers want? Do you have a specific interest or skills that could be relevant to your local community? For example, provision of a vaccination service for Hajj pilgrims  What are your competitors’ vulnerabilities?  Do you know of any plans by local businesses to change the services/products they offer which may put them in competition with you?  Is there a new pharmacy opening in your local area?  Do you have much competition from nearby pharmacies?  Do you know of any plans for the local surgery/surgeries to relocate or close?  Do you know of any planned future or ongoing local road works or car park works which may make your pharmacy less accessible?  Are you aware of internet pharmacies being advertised locally or providing services in the local area?

slide-16
SLIDE 16
  • bjectives – how

would you like your pharmacy to perform? Current performance – how is your pharmacy performing currently? Steps to achieve business objectives – how to bridge the gap Timescales (by end of) Responsibility of (name of person(s) responsible): For example: Pharmacist to carry out x NMS per financial year Pharmacist conducting X NMS per month  Use delivery drivers to help promote the service  Distribute leaflets to recruit eligible patients  Use alert stickers to highlight prescriptions for collection belonging to patients who are eligible for the service  NMS leaflets  July 2016  Pharmacy manager  Responsible Pharmacist

Gap analysis template

slide-17
SLIDE 17

NMS: future suggestions

  • APPG meeting in 2015 - unanimous in

supporting idea to offer NMS to patients with mental health conditions

  • Suggestions to extend service to include

patient groups :

  • Using anti-psychotic medicines
  • Depression
  • Gout
  • Glaucoma